Fig. 2.

Neutralization of SARS-CoV-2 Omicron variant in NP swab samples with FRIL from Lablab bean powder: (A) Images from clinical NP/OP swab samples of Patients #620 and #613 treated with FRIL bean powder (20,40,100 μg FRIL protein in 5,10 and 25 mg of bean powder respectively). (B) Number of microbubbles are quantified. All images share the same scale bar. Data were analyzed by One-way ANOVA test. There is a significant difference in the microbubble count between the Untreated vs FRIL bean powder at all concentrations. (***p-value < 0.0001). Omicron SARS-CoV-2 strain identification is based on whole genome sequencing or S gene target failure or date of collection. Please refer to Table 1 for other details on patient IDs.